ADAMAX 10mg – High-Purity Research Peptide
ADAMAX is a modified neuropeptide derived from the Semax peptide backbone, featuring N-terminal acetylation and a C-terminal adamantyl group. This structural modification is designed to enhance molecular stability and resistance to enzymatic degradation, making ADAMAX a compound of interest in advanced neuroscience and cognitive research models.
Supplied as a lyophilised (freeze-dried) solid, ADAMAX 10mg is manufactured under strict quality controls and verified at >99.1% purity via HPLC analysis. Each batch is accompanied by a full Certificate of Analysis (COA) to ensure consistency, transparency, and reproducibility in laboratory environments.
What is ADAMAX?
ADAMAX (also referred to as N-acetyl Semax-adamantyl) is a synthetic peptide analogue developed for research into neuroprotective pathways, synaptic signalling, and cognitive modulation. The adamantyl modification increases lipophilicity and molecular stability, allowing researchers to study prolonged peptide activity in experimental models.
Scientific Identifiers
-
Product Name: ADAMAX 10mg
-
Catalogue Number: BWP-ADMX-10
-
CAS Number: Not assigned (synthetic analogue)
-
Molecular Formula: C₂₂H₅₂N₁₆O₆
-
Molecular Weight: 1032.24 g/mol
-
Form: Lyophilised Solid
-
Purity: >99.1% (HPLC Verified)
-
Unit Size: 10mg
Usage and Storage
ADAMAX is supplied as a freeze-dried powder to maintain long-term stability. For laboratory research use, it may be reconstituted with bacteriostatic water or a suitable solvent according to established protocols. Store at −20°C, protected from light and moisture. Avoid repeated freeze–thaw cycles.
Legal and Safety Information
Bluewell Peptides products are supplied strictly for laboratory research and educational purposes only. They are not approved for human or veterinary use and are not intended to diagnose, treat, cure, or prevent any disease. Use must comply with all applicable laws and regulations.
